Omid Hamid MD
@omidhamidmd
Chief of Research and Immunotherapy • ImmunoOncology • Phase I Clinical Trials • Melanoma • Cutaneous Oncology
ID: 2171269956
http://www.theangelesclinic.org 03-11-2013 01:41:24
4,4K Tweet
4,4K Followers
810 Following
Appreciate ASCO The ASCO Post allowing me to discuss the future with Bispecific ImmTAC Immunocore #ASCO24 work done at many institutes including Cedars-Sinai The Angeles Clinic #Brenetefusp currently enrolling phase 3 trial for cutaneous #melanoma #ASCO24 ascopost.com/videos/2024-as…